Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Culprit drugs induce specific IL-36 overexpression in Acute Generalized Exanthematous Pustulosis.

Meier-Schiesser B, Feldmeyer L, Jankovic D, Mellett M, Satoh TK, Yerly D, Navarini A, Abe R, Yawalkar N, Chung WH, French LE, Contassot E.

J Invest Dermatol. 2018 Nov 2. pii: S0022-202X(18)32779-9. doi: 10.1016/j.jid.2018.10.023. [Epub ahead of print]

PMID:
30395846
2.

Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice.

Maul JT, Navarini AA, Sommer R, Anzengruber F, Sorbe C, Mrowietz U, Drach M, Blome C, Boehncke WH, Thaci D, Reich K, von Kiedrowski R, Körber A, Yawalkar N, Mainetti C, Laffitte E, Streit M, Rustenbach S, Conrad C, Borradori L, Gilliet M, Cozzio A, Itin P, Häusermann P, French LE, Radtke MA, Augustin M.

J Eur Acad Dermatol Venereol. 2018 Nov 2. doi: 10.1111/jdv.15324. [Epub ahead of print]

PMID:
30388318
3.

Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a Th1/Th17 immune response.

Thomi R, Schlapbach C, Yawalkar N, Simon D, Yerly D, Hunger RE.

Exp Dermatol. 2018 Feb;27(2):172-177. doi: 10.1111/exd.13482. Epub 2018 Jan 5.

PMID:
29222824
4.

The expanding spectrum of clinical phenotypes associated with PSTPIP1 mutations: from PAPA to PAMI syndrome and beyond.

Klötgen HW, Beltraminelli H, Yawalkar N, van Gijn ME, Holzinger D, Borradori L.

Br J Dermatol. 2018 Apr;178(4):982-983. doi: 10.1111/bjd.16136. Epub 2018 Feb 23. No abstract available.

PMID:
29150835
5.

TNFα and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNFα antagonists.

Deubelbeiss C, Kolios AGA, Anzengruber F, French LE, Yawalkar N, Kempf W, Kerl K, Meier B, Navarini AA.

J Cutan Pathol. 2018 Jan;45(1):23-28. doi: 10.1111/cup.13055. Epub 2017 Nov 22.

PMID:
29023827
6.

Apremilast for treatment of recalcitrant aphthous stomatitis.

Schibler F, Heidemeyer K, Klötgen HW, Keshavamurthy V, Yawalkar N.

JAAD Case Rep. 2017 Aug 30;3(5):410-411. doi: 10.1016/j.jdcr.2017.06.017. eCollection 2017 Sep. No abstract available.

7.

Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases.

Houriet C, Seyed Jafari SM, Thomi R, Schlapbach C, Borradori L, Yawalkar N, Hunger RE.

JAMA Dermatol. 2017 Nov 1;153(11):1195-1197. doi: 10.1001/jamadermatol.2017.2392. No abstract available.

PMID:
28854317
8.

Swiss S1 guideline for the treatment of rosacea.

Anzengruber F, Czernielewski J, Conrad C, Feldmeyer L, Yawalkar N, Häusermann P, Cozzio A, Mainetti C, Goldblum D, Läuchli S, Imhof L, Brand C, Laffitte E, Navarini AA.

J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1775-1791. doi: 10.1111/jdv.14349. Epub 2017 Aug 21. Review.

PMID:
28833645
9.

Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.

Chua-Aguilera CJ, Möller B, Yawalkar N.

Clin Rev Allergy Immunol. 2017 Dec;53(3):371-393. doi: 10.1007/s12016-017-8632-5. Review.

PMID:
28752373
10.

Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa.

Thomi R, Kakeda M, Yawalkar N, Schlapbach C, Hunger RE.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2091-2096. doi: 10.1111/jdv.14389. Epub 2017 Aug 29.

PMID:
28602023
11.

Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients.

Weber P, Seyed Jafari SM, Yawalkar N, Hunger RE.

J Am Acad Dermatol. 2017 Jun;76(6):1189-1191. doi: 10.1016/j.jaad.2017.02.026. No abstract available.

PMID:
28522043
12.

Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping.

Stekhoven D, Scherer A, Nissen MJ, Grobéty V, Yawalkar N, Villiger PM, Möller B; Swiss Clinical Quality Management for Rheumatic Diseases.

Clin Rheumatol. 2017 Sep;36(9):2035-2043. doi: 10.1007/s10067-017-3637-2. Epub 2017 Apr 22.

13.

Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab.

Page B, Borradori L, Beltraminelli H, Yawalkar N, Hunger RE.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e256-e257. doi: 10.1111/jdv.14282. Epub 2017 May 30. No abstract available.

PMID:
28430376
14.

Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.

Thomi R, Yerly D, Yawalkar N, Simon D, Schlapbach C, Hunger RE.

Br J Dermatol. 2017 Nov;177(5):1358-1366. doi: 10.1111/bjd.15458. Epub 2017 Sep 27.

PMID:
28301691
15.

Generalized Comedones, Acne, and Hidradenitis Suppurativa in a Patient with an FGFR2 Missense Mutation.

Higgins R, Pink A, Hunger R, Yawalkar N, Navarini AA.

Front Med (Lausanne). 2017 Feb 28;4:16. doi: 10.3389/fmed.2017.00016. eCollection 2017.

16.

Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris.

Feldmeyer L, Mylonas A, Demaria O, Mennella A, Yawalkar N, Laffitte E, Hohl D, Gilliet M, Conrad C.

JAMA Dermatol. 2017 Apr 1;153(4):304-308. doi: 10.1001/jamadermatol.2016.5384.

17.

Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry.

Jungo P, Maul JT, Djamei V, von Felten S, Kolios AGA, Czernielewsk J, Yawalkar N, Odermatt O, Laffitte E, Anliker M, Streit M, Augustin M, Conrad C, Hafner J, Boehncke WH, Gilliet M, Itin P, French LE, Navarini AA, Häusermann P.

Dermatology. 2016;232(6):655-663. doi: 10.1159/000455042. Epub 2017 Jan 20.

18.

Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT.

Maul JT, Djamei V, Kolios AGA, Meier B, Czernielewski J, Jungo P, Yawalkar N, Mainetti C, Laffitte E, Spehr C, Anliker M, Streit M, Augustin M, Rustenbach S, Conrad C, Hafner J, Boehncke WH, Borradori L, Gilliet M, Itin P, French LE, Häusermann P, Navarini AA.

Dermatology. 2016;232(6):640-647. doi: 10.1159/000452740. Epub 2017 Jan 12.

19.

Development of psoriasis in IBD patients under TNF-antagonist therapy is associated neither with anti-TNF-antagonist antibodies nor trough levels.

Protic M, Schoepfer A, Yawalkar N, Vavricka S, Seibold F.

Scand J Gastroenterol. 2016 Dec;51(12):1482-1488. Epub 2016 Aug 18.

PMID:
27534974
20.

Ingenol Mebutate for Lentigo Maligna: A Case Report.

Gadaldi K, Feldmeyer L, Yawalkar N, Hunger RE.

Dermatology. 2016;232 Suppl 1:24-8. doi: 10.1159/000447393. Epub 2016 Aug 11.

21.

Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy.

Feldmeyer L, Heidemeyer K, Yawalkar N.

Int J Mol Sci. 2016 Jul 27;17(8). pii: E1214. doi: 10.3390/ijms17081214. Review.

22.

Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris.

Kolios AG, Yawalkar N, Anliker M, Boehncke WH, Borradori L, Conrad C, Gilliet M, Häusermann P, Itin P, Laffitte E, Mainetti C, French LE, Navarini AA.

Dermatology. 2016;232(4):385-406. doi: 10.1159/000445681. Epub 2016 Jun 21.

23.

IgE and FcεRI are highly expressed on innate cells in psoriasis.

Yan KX, Huang Q, Fang X, Zhang ZH, Han L, Gadaldi K, Kang KF, Zheng ZZ, Xu JH, Yawalkar N.

Br J Dermatol. 2016 Jul;175(1):122-33. doi: 10.1111/bjd.14459. Epub 2016 Apr 18.

PMID:
26853903
24.

Prognostic markers in lentigo maligna patients treated with imiquimod cream: A long-term follow-up study.

Gautschi M, Oberholzer PA, Baumgartner M, Gadaldi K, Yawalkar N, Hunger RE.

J Am Acad Dermatol. 2016 Jan;74(1):81-87.e1. doi: 10.1016/j.jaad.2015.08.031. Epub 2015 Oct 23.

PMID:
26601565
25.

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.

Nast A, Gisondi P, Ormerod AD, Saiag P, Smith C, Spuls PI, Arenberger P, Bachelez H, Barker J, Dauden E, de Jong EM, Feist E, Jacobs A, Jobling R, Kemény L, Maccarone M, Mrowietz U, Papp KA, Paul C, Reich K, Rosumeck S, Talme T, Thio HB, van de Kerkhof P, Werner RN, Yawalkar N.

J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2277-94. doi: 10.1111/jdv.13354. Epub 2015 Oct 19. No abstract available.

PMID:
26481193
26.

Canakinumab in adults with steroid-refractory pyoderma gangrenosum.

Kolios AG, Maul JT, Meier B, Kerl K, Traidl-Hoffmann C, Hertl M, Zillikens D, Röcken M, Ring J, Facchiano A, Mondino C, Yawalkar N, Contassot E, Navarini AA, French LE.

Br J Dermatol. 2015 Nov;173(5):1216-23. doi: 10.1111/bjd.14037. Epub 2015 Oct 16.

27.

Successful Treatment of Recalcitrant Prurigo with Alitretinoin.

Gadaldi K, Erdemoğlu Y, Yawalkar N.

Dermatology. 2015;231(4):330-3. doi: 10.1159/000435911. Epub 2015 Aug 22.

28.

The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists.

Boehncke WH, Anliker MD, Conrad C, Dudler J, Hasler F, Hasler P, Häusermann P, Kyburz D, Laffitte E, Michel BA, Möller B, Navarini AA, Villiger PM, Yawalkar N, Gabay C.

Dermatology. 2015;230(1):75-81. doi: 10.1159/000367688. Epub 2015 Jan 6.

29.

Extracorporeal shock wave therapy for injection site panniculitis in multiple sclerosis patients.

Stieger M, Schmid JP, Yawalkar N, Hunziker T.

Dermatology. 2015;230(1):82-6. doi: 10.1159/000368351. Epub 2014 Dec 5.

PMID:
25502016
30.

Homozygous missense mutation in IL36RN in generalized pustular dermatosis with intraoral involvement compatible with both AGEP and generalized pustular psoriasis.

Navarini AA, Simpson MA, Borradori L, Yawalkar N, Schlapbach C.

JAMA Dermatol. 2015 Apr;151(4):452-3. doi: 10.1001/jamadermatol.2014.3848. No abstract available.

PMID:
25427108
31.

Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis.

Kakeda M, Schlapbach C, Danelon G, Tang MM, Cecchinato V, Yawalkar N, Uguccioni M.

Arch Dermatol Res. 2014 Dec;306(10):933-8. doi: 10.1007/s00403-014-1488-0. Epub 2014 Jul 17.

PMID:
25030504
32.

Increased expression of heat shock protein 90 in keratinocytes and mast cells in patients with psoriasis.

Kakeda M, Arock M, Schlapbach C, Yawalkar N.

J Am Acad Dermatol. 2014 Apr;70(4):683-690.e1. doi: 10.1016/j.jaad.2013.12.002. Epub 2014 Feb 9.

PMID:
24521827
33.

Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.

Schlapbach C, Gehad A, Yang C, Watanabe R, Guenova E, Teague JE, Campbell L, Yawalkar N, Kupper TS, Clark RA.

Sci Transl Med. 2014 Jan 15;6(219):219ra8. doi: 10.1126/scitranslmed.3007828.

34.

Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis.

Strohal R, Kirby B, Puig L; Psoriasis Expert Panel, Girolomoni G, Kragballe K, Luger T, Nestle FO, Prinz JC, Ståhle M, Yawalkar N.

J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1661-9. doi: 10.1111/jdv.12350. Epub 2013 Dec 24.

35.

Cytokines and chemokines in irritant contact dermatitis.

Lee HY, Stieger M, Yawalkar N, Kakeda M.

Mediators Inflamm. 2013;2013:916497. doi: 10.1155/2013/916497. Epub 2013 Nov 25. Review.

36.

Adalimumab in recalcitrant severe psoriasis associated with atopic dermatitis.

Yayli S, Irla N, Yawalkar N.

Case Rep Dermatol. 2013 Nov 14;5(3):332-5. doi: 10.1159/000356776. eCollection 2013.

37.

Rapid downregulation of innate immune cells, interleukin-12 and interleukin-23 in generalized pustular psoriasis with infliximab in combination with acitretin.

Tang MM, Spanou Z, Tang H, Schibler F, Pelivani N, Yawalkar N.

Dermatology. 2012;225(4):338-43. doi: 10.1159/000346243. Epub 2013 Jan 18. Review.

38.

Severe cutaneous allergic reactions following topical antifungal therapy.

Tang MM, Corti MA, Stirnimann R, Pelivani N, Yawalkar N, Borradori L, Simon D.

Contact Dermatitis. 2013 Jan;68(1):56-7. doi: 10.1111/j.1600-0536.2012.02151.x. No abstract available.

PMID:
23227869
39.

Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients.

Zecca C, Yawalkar N, Gobbi C.

Patient Prefer Adherence. 2012;6:565-7. doi: 10.2147/PPA.S33727. Epub 2012 Aug 8.

40.

Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis.

Irla N, Navarini AA, Yawalkar N.

Br J Dermatol. 2012 Nov;167(5):1170-4. doi: 10.1111/j.1365-2133.2012.11063.x. Epub 2012 Sep 13.

PMID:
22612660
41.

Acute life-threatening extrinsic allergic alveolitis in a paint controller.

Bieler G, Thorn D, Huynh CK, Tomicic C, Steiner UC, Yawalkar N, Danuser B.

Occup Med (Lond). 2011 Sep;61(6):440-2. doi: 10.1093/occmed/kqr057. Epub 2011 Aug 8.

42.

NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions.

Schlapbach C, Zawodniak A, Irla N, Adam J, Hunger RE, Yerly D, Pichler WJ, Yawalkar N.

Allergy. 2011 Nov;66(11):1469-76. doi: 10.1111/j.1398-9995.2011.02677.x. Epub 2011 Aug 5.

PMID:
21819408
43.

Amicrobial pustulosis-like rash in a patient with Crohn's disease under anti-TNF-alpha blocker.

Lee HY, Pelivani N, Beltraminelli H, Hegyi I, Yawalkar N, Borradori L.

Dermatology. 2011;222(4):304-10. doi: 10.1159/000329428. Epub 2011 Jul 15. Review.

PMID:
21757882
44.

Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa.

Schlapbach C, Hänni T, Yawalkar N, Hunger RE.

J Am Acad Dermatol. 2011 Oct;65(4):790-798. doi: 10.1016/j.jaad.2010.07.010.

PMID:
21641076
45.

Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphoma.

Schlapbach C, Yerly D, Daubner B, Yawalkar N, Hunger RE.

J Dermatol Sci. 2011 May;62(2):75-83. doi: 10.1016/j.jdermsci.2011.02.001. Epub 2011 Feb 15.

PMID:
21377838
46.

Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.

Naldi L, Yawalkar N, Kaszuba A, Ortonne JP, Morelli P, Rovati S, Mautone G.

Am J Clin Dermatol. 2011 Jun 1;12(3):191-201. doi: 10.2165/11539780-000000000-00000.

PMID:
21284407
47.

Nail Lichen Planus: Successful Treatment with Etanercept.

Irla N, Schneiter T, Haneke E, Yawalkar N.

Case Rep Dermatol. 2010 Oct 21;2(3):173-176.

48.

Definition of treatment goals for moderate to severe psoriasis: a European consensus.

Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Daudén E, Gisondi P, Iversen L, Kemény L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N.

Arch Dermatol Res. 2011 Jan;303(1):1-10. doi: 10.1007/s00403-010-1080-1. Epub 2010 Sep 21.

49.

High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma.

Schlapbach C, Ochsenbein A, Kaelin U, Hassan AS, Hunger RE, Yawalkar N.

J Am Acad Dermatol. 2010 Jun;62(6):995-1004. doi: 10.1016/j.jaad.2009.06.082.

PMID:
20466174
50.

Characterization of dendritic cells and macrophages in irritant contact dermatitis.

Tang H, Schlapbach C, Hassan AS, Simon D, Yawalkar N.

J Dermatol Sci. 2010 Mar;57(3):216-8. doi: 10.1016/j.jdermsci.2010.01.001. Epub 2010 Jan 21. No abstract available.

PMID:
20138475

Supplemental Content

Loading ...
Support Center